Yan Yu

2.1k total citations
63 papers, 1.5k citations indexed

About

Yan Yu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Yu has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Yu's work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Epigenetics and DNA Methylation (7 papers). Yan Yu is often cited by papers focused on Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Epigenetics and DNA Methylation (7 papers). Yan Yu collaborates with scholars based in China, United States and Australia. Yan Yu's co-authors include Jin Shi, Dehai Che, Sarah Shigdar, Wei Ming, Jia Lin, Wei Duan, Lihua Shang, Jing Shen, Jingyan Cao and Bo Pan and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yan Yu

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Yu China 21 724 455 336 302 223 63 1.5k
Sajni Josson United States 19 1.0k 1.4× 350 0.8× 860 2.6× 178 0.6× 306 1.4× 24 1.7k
Zhifei Xu China 25 763 1.1× 322 0.7× 193 0.6× 155 0.5× 330 1.5× 101 1.7k
Chenxi Hu China 18 440 0.6× 202 0.4× 214 0.6× 107 0.4× 120 0.5× 65 930
Donghui Han China 19 422 0.6× 210 0.5× 160 0.5× 159 0.5× 284 1.3× 56 1.1k
Tadashi Igishi Japan 22 1.2k 1.6× 528 1.2× 207 0.6× 168 0.6× 354 1.6× 68 2.1k
Zhiyuan Lin China 15 274 0.4× 178 0.4× 112 0.3× 145 0.5× 198 0.9× 35 1.0k
Yun Yang China 29 1.4k 2.0× 231 0.5× 660 2.0× 314 1.0× 111 0.5× 85 2.3k
Jiaojiao Zhou China 21 795 1.1× 725 1.6× 547 1.6× 164 0.5× 197 0.9× 57 1.7k
Weijie Liao China 13 684 0.9× 122 0.3× 479 1.4× 121 0.4× 99 0.4× 41 1.1k
Jiexia Zhang China 18 358 0.5× 425 0.9× 248 0.7× 59 0.2× 335 1.5× 69 1.0k

Countries citing papers authored by Yan Yu

Since Specialization
Citations

This map shows the geographic impact of Yan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Yu more than expected).

Fields of papers citing papers by Yan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Yu. The network helps show where Yan Yu may publish in the future.

Co-authorship network of co-authors of Yan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Yu. A scholar is included among the top collaborators of Yan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Yu. Yan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yi, et al.. (2025). Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights. Frontiers in Immunology. 16. 1584450–1584450. 4 indexed citations
4.
Zhou, Yi, Xinyu Xiong, Zhe Cheng, et al.. (2024). Ginsenoside Rb1 Alleviates DSS-Induced Ulcerative Colitis by Protecting the Intestinal Barrier Through the Signal Network of VDR, PPARγ and NF-κB. Drug Design Development and Therapy. Volume 18. 4825–4838. 5 indexed citations
5.
Shen, Dong, Miaochun Cai, Yi Luo, et al.. (2024). Sex disparities in the risk of intracranial aneurysm rupture: a case–control study. Frontiers in Neurology. 15. 1483679–1483679.
7.
Wu, Lin, Yan Yu, & Yan Xu. (2023). Induction Immunochemotherapy Followed by Definitive Chemoradiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e75–e75.
8.
Liu, Nan, Yi Guan, Yan Yu, et al.. (2022). Pulmonary effects of exposure to indium and its compounds: cross-sectional survey of exposed workers and experimental findings in rodents. Particle and Fibre Toxicology. 19(1). 69–69. 7 indexed citations
10.
Zhu, Lizhe, Wei Wu, Siyuan Jiang, et al.. (2020). Pan-Cancer Analysis of the Mitophagy-Related Protein PINK1 as a Biomarker for the Immunological and Prognostic Role. Frontiers in Oncology. 10. 569887–569887. 24 indexed citations
11.
Li, Qi, Fang Liu, Feng Zhang, et al.. (2018). lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis. Biomedicine & Pharmacotherapy. 103. 1507–1515. 65 indexed citations
12.
Che, Dehai, Shuai Zhang, Lihua Shang, et al.. (2017). Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE2/β-catenin signalling pathway. Molecular Immunology. 90. 197–210. 113 indexed citations
13.
Cao, Jingyan, Jin Shi, Liyan Lv, et al.. (2016). Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways. Molecular and Cellular Biochemistry. 415(1-2). 1–11. 30 indexed citations
14.
Ge, Guanqun, Can Zhou, Yu Ren, et al.. (2015). Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling. Tumor Biology. 37(4). 5049–5062. 37 indexed citations
15.
Pan, Bo, Jing Shen, Jingyan Cao, et al.. (2015). Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Scientific Reports. 5(1). 16053–16053. 131 indexed citations
16.
Shi, Jin, Shoubo Cao, Jingyan Cao, et al.. (2014). Predictive Factors Analysis for Malignant Peritoneal Mesothelioma. Journal of Gastrointestinal Surgery. 19(2). 319–326. 7 indexed citations
17.
Pan, Bo, Qiang Tian, Fang Liu, et al.. (2014). Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6. Immunology Letters. 160(1). 1–10. 74 indexed citations
18.
You, Qidong, Shichang Kang, Guoyu Ren, et al.. (2011). Observed changes in snow depth and number of snow days in the eastern and central Tibetan Plateau. Climate Research. 46(2). 171–183. 69 indexed citations
19.
You, Qidong, et al.. (2010). Decreasing wind speed and weakening latitudinal surface pressure gradients in the Tibetan Plateau. Climate Research. 42(1). 57–64. 68 indexed citations
20.
Chen, S M, et al.. (2010). Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells. The Journal of Laryngology & Otology. 124(7). 778–783. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026